Dropout: Rethinking Pharma's Next Growth Lever with Mohamed El-Zayat

Scaling the Doctor: Inside Elfie’s First Government MOU for AI-Powered Care

What does it take for a government to put its name behind an AI health platform? In this episode of Elfie Voices: Rethinking Health, Grace McNamara sits down with Elfie co-founders Ofir and JF to unpack a landmark moment: their first Memorandum of Understanding with a government to deploy ELFIECARE across doctors and hospitals — free of charge. After five years proving the hardest thing in digital health — patient engagement — Elfie’s data surfaced a defining insight: the doctor is the single biggest agent of change, with doctor-referred patients showing double the adherence and double the impact. That insight reshaped the company’s next move: empowering clinicians with conversational AI that plugs into existing workflows on WhatsApp, never replacing the systems already in place. Ofir and JF lay out the economics that make Ministries of Health pay attention — exploding chronic-disease costs, the urgent need to “scale the doctor,” and a model that delivers controlled, compliant AI with local data residency in markets the big cloud providers don’t even serve. They explain why Elfie’s moat is the difficult path most vendors avoid: free deployment, ministry authorization, demonstrated medical impact, and a real-time epidemiologic data layer that finally lets governments and pharma see whether their spending actually works. For leaders in government and pharma, this is a candid look at how to align short-term incentives toward long-term population health — and how rigorous AI governance Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

The Unexpected Cost of Ignoring Venous Disease

Venous disease doesn’t have to be just a cosmetic concern—it's a hidden indicator of broader cardiovascular health that’s often overlooked. Why are we failing to measure and prioritize venous health at the system level—and what’s at stake if we don’t change? In this eye-opening episode, Dr. Vito Ademe, an interventional vascular cardiologist and passionate phlebologist, reveals how under-measurement and under-recording of venous disease leave millions at risk of costly, preventable complications. You’ll discover how venous disease is more prevalent than many realize and how it silently contributes to heart failure, strokes, and systemic inflammation. Dr. Vito breaks down the critical link between venous health and cardiovascular risk, emphasizing the importance of systemic measurement and early detection. Learn about groundbreaking concepts like “wellness phlebology,” where understanding the root causes of venous issues can prevent systemic health decline long before crises occur. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Dropout: Rethinking Pharma's Next Growth Lever with Mohamed El-Zayat

What if the biggest threat to your blockbuster isn't a competing molecule — but the patient who quietly stops refilling after month two? In this episode, Grace McNamara sits down with Mohamed El-Zayat, Elfie's new Country Manager for Egypt and the Middle East and a 22-year pharma veteran (Pfizer, AstraZeneca, Merck) across marketing, global brand leadership, and patient access. Mohamed breaks down the three hidden competitors every chronic-disease brand faces — therapy dropout, the shrinking HCP-patient consult, and the post-prescription data blackout — and explains why a connected patient ecosystem, not another standalone app, is the strategic unlock. Inside the conversation: * Why adherence, not rival brands, is the real battleground in chronic care * How Elfie Care is positioned to be "the most significant launch in healthcare in the next 10 years" * Why longitudinal, patient-reported + wearable + lab data is pharma's next real-world evidence goldmine * The economics of replacing 65 fragmented PSP apps with one ecosystem spanning pharma, payers, ministries, HCPs, and pharmacies * What insurers, ministries of health, and brand teams should be asking now A sharp, strategic listen for pharma executives, patient access leaders, RWE teams, and payer innovators. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Are We Undervaluing The Power Of Nutrition?

Most health systems overlook one of the most impactful, cost-effective tools in chronic disease: food. What if nutrition was not just lifestyle advice, but a direct, measurable clinical intervention? In this episode of Elfie Voices, Aya speaks with Débora Gapanowicz, a dietitian specialising in diabetes and functional nutrition, about rethinking the role of food in population health. Débora explains how everyday dietary choices can shape cardiometabolic biomarkers in real time, from blood glucose to blood pressure, highlighting nutrition as a powerful but often underused part of care. The conversation explores why nutrition has historically sat outside clinical practice, how digital platforms like Elfie are helping make it more measurable, and what the economic case looks like for integrating it more formally into healthcare systems. A thoughtful shift in perspective, with real implications for prevention, cost, and long-term outcomes. Follow us: LinkedIn: ⁠⁠⁠⁠⁠⁠Elfie⁠⁠⁠⁠⁠⁠ [https://www.linkedin.com/company/elfieco] Instagram: ⁠⁠⁠⁠⁠⁠Elfie.en⁠⁠⁠⁠⁠⁠ [https://www.instagram.com/elfie.en/] Facebook: ⁠⁠⁠⁠⁠Elfie Global [https://www.facebook.com/elfie.global]

Introducing Elfie for WhatsApp — Chronic Care Management Comes to the World's Most Used Chat

Elfie is bringing its full AI-powered chronic disease management platform to WhatsApp. Medication tracking, nutrition analysis, lab results, and real-time health coaching — all inside a conversation on the chat interface 2 billion people already use every day. No app download. No training. No storage barrier. In this episode of ElfieVoices: Rethinking Health, co-founders JF and Ofir join Grace to walk through what's coming and why it matters. For pharma: proactive adherence nudges that meet patients where they already are, replacing the compliance behaviors they can't sustain.  For insurers: an AI engine that plugs into existing member apps without new infrastructure. For patients everywhere: a health coach available 24/7 in the chat they already use daily. They also take on the security question head-on — why WhatsApp's Business API actually reduces vulnerability points, stores zero patient data, and delivers end-to-end encryption most health apps can't match. Launching this summer.